Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The impact of managed care on research: the changing face of medicine.

Skirboll LR.

Acad Med. 1997 Sep;72(9):778-9. No abstract available.

PMID:
9311319
2.
3.

Anatomical analysis of frontal cortex sites at which carbachol induces motor seizures in the rat.

Stivers JA, Skirboll LR, Long R, Crawley JN.

Pharmacol Biochem Behav. 1988 May;30(1):129-36.

PMID:
3174734
4.

Preferential effects of caffeine on limbic and cortical dopamine systems.

Stoner GR, Skirboll LR, Werkman S, Hommer DW.

Biol Psychiatry. 1988 Apr 15;23(8):761-8.

PMID:
2835113
7.
8.
9.

Neurotensin in the rat median eminence: the possible sources of neurotensin-like fibers and varicosities in the external layer.

Kiss A, Palkovits M, Antoni FA, Eskay RL, Skirboll LR.

Brain Res. 1987 Jul 21;416(1):129-35.

PMID:
3304533
10.

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype.

Hommer DW, Stoner G, Crawley JN, Paul SM, Skirboll LR.

J Neurosci. 1986 Oct;6(10):3039-43.

11.

Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.

Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.

J Pharmacol Exp Ther. 1986 Feb;236(2):320-30.

PMID:
3003339
12.

Functional studies of cholecystokinin-dopamine co-existence: electrophysiology and behavior.

Skirboll LR, Crawley JN, Hommer DW.

Prog Brain Res. 1986;68:357-70. No abstract available.

PMID:
3562851
13.

Electrophysiological actions of nicotine on substantia nigra single units.

Clarke PB, Hommer DW, Pert A, Skirboll LR.

Br J Pharmacol. 1985 Aug;85(4):827-35.

14.
15.

Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.

Hommer DW, Palkovits M, Crawley JN, Paul SM, Skirboll LR.

J Neurosci. 1985 Jun;5(6):1387-92.

16.
17.

Demonstration of a pontine-hippocampal projection containing a ranatensin-like peptide.

Chronwall BM, Skirboll LR, O'Donohue TL.

Neurosci Lett. 1985 Jan 7;53(1):109-14.

PMID:
3887223
18.

Electrophysiological studies of the role of cholecystokinin in the substantia nigra and its interactions with dopamine.

Skirboll LR, Hommer DW.

Ann N Y Acad Sci. 1985;448:275-82. No abstract available.

PMID:
3861121
19.

Cholecystokinin and cultured spinal neurons. Immunohistochemistry, receptor binding, and neurophysiology.

Rogawski MA, Beinfeld MC, Hays SE, Hökfelt T, Skirboll LR.

Ann N Y Acad Sci. 1985;448:403-12. No abstract available.

PMID:
2992347
20.

Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline.

Mezey E, Kiss JZ, Skirboll LR, Goldstein M, Axelrod J.

Nature. 1984 Jul 12-18;310(5973):140-1.

PMID:
6377089
21.
22.
23.

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons.

Hommer DW, Skirboll LR.

Eur J Pharmacol. 1983 Jul 15;91(1):151-2. No abstract available.

PMID:
6617736
24.

Hypothalamic gamma-aminobutyric acid neurons project to the neocortex.

Vincent SR, Hökfelt T, Skirboll LR, Wu JY.

Science. 1983 Jun 17;220(4603):1309-11.

PMID:
6857253
25.

Effect of cholecystokinin of the activity of midbrain dopaminergic neurons.

Bunney BS, Grace AA, Hommer DW, Skirboll LR.

Adv Biochem Psychopharmacol. 1982;33:429-36. No abstract available.

PMID:
7124507
26.

Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons.

Skirboll LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, Hökfelt T, Bunney BS.

Neuroscience. 1981;6(11):2111-24. No abstract available.

PMID:
6120481
27.

Dopamine auto- and postsynaptic receptors: possible interference by gallamine.

Grace AA, Skirboll LR, Bunney BS.

Science. 1980 Aug 8;209(4457):721. No abstract available.

PMID:
17821196
28.

Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.

Bannon MJ, Bunney EB, Zigun JR, Skirboll LR, Roth RH.

Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):161-5.

PMID:
6772975
29.

Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity.

Bunney BS, Skirboll LR, Grace AA.

Adv Biochem Psychopharmacol. 1980;24:267-73. No abstract available.

PMID:
7405666
30.

The effect of verapamil on the gastrocnemius and soleus muscles of the cat in vivo.

Skirboll LR, Howard RA, Dretchen KL.

Eur J Pharmacol. 1979 Nov 23;60(1):15-21.

PMID:
520414
31.

The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat.

Skirboll LR, Bunney BS.

Life Sci. 1979 Oct 15;25(16):1419-33. No abstract available.

PMID:
522610
32.
33.

Effects of calcium on a cyclic nucleotide system in soleus motor nerve terminals.

Skirboll LR, Standaert FG, Dretchen KL.

Eur J Pharmacol. 1979 Mar 1;54(3):295-8.

PMID:
218825
34.

Evidence for a cyclic nucleotide-mediated calcium flux in motor nerve terminals.

Skirboll LR, Baizer L, Dretchen KL.

Nature. 1977 Jul 28;268(5618):352-5. No abstract available.

PMID:
196215
35.

A role of cyclic nucleotides in neuromuscular transmission.

Standaert FG, Dretchen KL, Skirboll LR, Morgenroth VH 3rd.

J Pharmacol Exp Ther. 1976 Dec;199(3):553-64.

PMID:
186585
36.

Effects of cyclic nucleotides on mammalian motor nerve terminals.

Standaert FG, Dretchen KL, Skirboll LR, Morgenroth VH 3rd.

J Pharmacol Exp Ther. 1976 Dec;199(3):544-52.

PMID:
186584
37.

Evidence for a prejunctional role of cyclic nucleotides in neuromuscular transmission.

Dretchen KL, Standaert FG, Skirboll LR, Morgenroth VH 3rd.

Nature. 1976 Nov 4;264(5581):79-81. No abstract available.

PMID:
187946
38.

Basis for posttetanic potentiation at the mammalian neuromuscular junction.

Wilson DF, Skirboll LR.

Am J Physiol. 1974 Jul;227(1):92-5. No abstract available.

PMID:
4843361

Supplemental Content

Loading ...
Support Center